Lilly’s TuneLab Is Democratizing AI for Drug Discovery The pharmaceutical industry is experiencing a transformative shift as Eli Lilly introduces TuneLab , a sophisticated artificial intelligence platform designed to accelerate and democratize drug discov... AI drug discovery biotechnology Eli Lilly healthcare innovation machine learning pharmaceuticals research partnerships
Generative AI: Transforming Hope for Rare Disease Patients Millions of people worldwide face the daily reality of rare diseases, many of which have no approved therapies. Traditional drug development often overlooks these conditions due to high costs and limi... AI drug discovery ALS biotechnology clinical trials generative AI IPF medical research rare diseases
AI-Discovered Drug Enters Phase II: Transforming the Future of Clinical Trials For the first time in history, a drug designed entirely by generative artificial intelligence has moved into Phase II clinical trials with patients. INS018_055, developed by Insilico Medicine , target... AI drug discovery biotechnology clinical trials drug development generative AI pharma innovation pulmonary fibrosis
AI In Drug Discovery: From Protein Structures to Molecular Interactions Artificial intelligence is reshaping drug discovery, moving well beyond predicting static protein structures to modeling the intricate dance of biomolecular interactions. This leap is enabling scienti... AI drug discovery AlphaFold biopharma innovation biotechnology computational biology machine learning protein interactions therapeutic design